| Literature DB >> 30336388 |
Ébe Dos Santos Monteiro Carbone1, Mayara Ronzini Takaki2, Maria Gabriela Baumgarten Kuster Uyeda3, Marair Gracio Ferreira Sartori3.
Abstract
PURPOSE: To implement a physical therapy intervention protocol targeting patients admitted for gynaecological surgery to the gynaecological ward of XXXX Hospital.Entities:
Keywords: Early ambulation; Gynecology; Physical therapy
Year: 2018 PMID: 30336388 PMCID: PMC6197772 DOI: 10.1016/j.ijscr.2018.09.051
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1Flowchart representing the participants of the ORIGAMI Project–physical therapy intervention.
Description of the participants’ characteristics—age, race and comorbidities.
| Phase I | Phase II | Phase III | p¹ | |
|---|---|---|---|---|
| age; mean ± SD | 51.07 ± 14.35 (n = 197) | 50.62 ± 15.43 (n = 178) | 49.6 ± 14.65 (n = 190) | 0.608² |
| 192 | 177 | 185 | ||
| Asian | 1 (0.52%) | 2 (1.13%) | 2 (1.08%) | 0.287 |
| White | 118 (61.46%) | 120 (67.8%) | 119 (64.32%) | |
| Native American | 3 (1.56%) | 0 | 0 | |
| Black | 8 (4.17%) | 10 (5.65%) | 13 (7.03%) | |
| Mixed | 62 (32.29%) | 45 (25.42%) | 51 (27.57%) | |
| 197 | 178 | 190 | ||
| Heart disease | 8 (4.06%) | 5 (2.81%) | 5 (2.63%) | 0.684 |
| DLP | 22 (11.17%) | 19 (10.67%) | 28 (14.74%) | 0.423 |
| DM | 28 (14.21%) | 39 (21.91%) | 34 (17.89%) | 0.152 |
| SAH | 87 (44.16%) | 73 (41.01%) | 73 (38.42%) | 0.517 |
| SAH and DM | 28 (14.21%) | 32 (17.98%) | 29 (15.26%) | 0.592 |
| Hyperthyroidism | 2 (1.02%) | 0 | 1 (0.53%) | 0.402 |
| Hypothyroidism | 26 (13.2%) | 19 (10.67%) | 19 (10%) | 0.578 |
| HIV | 2 (1.02%) | 2 (1.12%) | 2 (1.05%) | 0.995 |
| CKF | 1 (0.51%) | 1 (0.56%) | 1 (0.53%) | 0.997 |
| Rheumatologic | 3 (1.52%) | 9 (5.06%) | 2 (1.05%) | 0.027 |
| Asthma | 0 | 0 | 4 (2.11%) | 0.019 |
| Kidney disease | 0 | 0 | 2 (1.05%) | 0.138 |
| Neoplasm | 1 (0.51%) | 11 (6.18%) | 3 (1.58%) | 0.002 |
| Stroke | 1 (0.51%) | 3 (1.69%) | 1 (0.53%) | 0.387 |
| Chagas | 0 | 0 | 1 (0.53%) | 0.372 |
| Sickle cell | 0 | 0 | 1 (0.53%) | 0.372 |
| Hepatitis B | 1 (0.51%) | 0 | 0 | 0.392 |
| Hepatitis C | 2 (1.02%) | 1 (0.56%) | 2 (1.05%) | 0.856 |
| Parkinson | 0 | 1 (0.56%) | 0 | 0.337 |
| DVT | 4 (2.03%) | 3 (1.69%) | 2 (1.05%) | 0.739 |
| Smoking | 23 (11.68%) | 25 (14.12%) | 24 (12.63%) | 0.776 |
(SAH) systemic arterial hypertension; (DM) diabetes mellitus; (DLP) dyslipidaemia; (HIV+) human immunodeficiency virus; (CKF) chronic kidney failure; (DVT) deep vein thrombosis. (1) Chi-square test. (2) ANOVA F test.
Comparative analysis of time to onset of ambulation and length of hospital stay among study phases.
| Variables | Phase I | Phase II | Phase III | p |
|---|---|---|---|---|
| (n = 197) | (n = 178) | (n = 190) | ||
| Time to ambulation | 16.65 ± 8.87 | 13.85 ± 8.02 | 13.50 ± 7.62 | <0.001¹ |
| Median/IQR | 16.67 [13.5–20.75] | 15.21 [6.71–18.43] | 13.83 [7–18.17] | <0.001¹ |
| Length of hospital stay | 77.79 ± 65.13 | 72.36 ± 48.78 | 60.26 ± 31.68 | 0.011¹ |
| Median/IQR | 52.85 [50.13–76.8] | 52.22 [49.23–74.83] | 51.65 [48.53–71.3] | 0.011¹ |
SD: standard deviation; IQR: interquartile range; (1) Kruskal-Wallis test; (2) Fisher’s exact test.
Length of hospital stay of participants who began ambulation before or after 16 h since surgery.
| Phase | Length of stay at hospital | P¹ | |||
|---|---|---|---|---|---|
| Ambulation | Ambulation | Total (n = 381) | |||
| I | mean ± SD | 63.3 ± 33.2 | 90.4 ± 76.8 | 78.5 ± 62.9 | 0.008 |
| median [IQR] | 51.4 [48.1–74.7] | 58.3 [51.5–98.9] | 53.5 [50.5–75] | ||
| II | mean ± SD | 58.8 ± 34.4 | 85.2 ± 46.5 | 69.5 ± 41.7 | <0.001 |
| median [IQR] | 50.7 [46.3–55.9] | 72 [51–100.1] | 52.2 [48.8–73.9] | ||
| III | mean ± SD | 55.9 ± 29.6 | 69.4 ± 36 | 60.8 ± 32.6 | <0.001 |
| median [IQR] | 50.1 [48.2–53] | 54.7 [51.3–75.5] | 51.6 [49–69.1] | ||
| Total | mean ± SD | 58.8 ± 32.4 | 83 ± 58.2 | 69.4 ± 47 | <0.001 |
| median [IQR] | 50.8 [48–55.5] | 68.1 [51.1–95.5] | 52.4 [49.2–73.7] | ||
(1)Student’s t-test.
Correlation of walked distance with access route and magnitude of surgery.
| Variables | PHASE I | PHASE II | PHASE III | p value | |||||
|---|---|---|---|---|---|---|---|---|---|
| Amb | Amb PO1 metres | Amb IPO metres | Amb PO1 metres | Amb IPO metres | PO1 | IPO | |||
| N = 85 | N = 178 | N = 155 | N = 130 | N = 139 | I vs. | I vs. | II vs. III | II vs. III | |
| Abdominal | 58.4 ± 46.1 | 168 ± 22 | 67 ± 52 | 193.1 ± 84.1 | 51.9 ± 45.1 | 0.030 | <0.001 | 0.780 | 0.747 |
| n = 16 | n = 16 | n = 16 | n = 15 | n = 15 | |||||
| Hysteroscopic or endovascular | 53.2 ± 61.8 | 303.4 ± 174.8 | 89.1 ± 131.7 | 251.8 ± 125.9 | 70.9 ± 51.9 | <0.001 | <0.001 | 0.158 | 0.455 |
| n = 14 | n = 61 | n = 43 | n = 29 | n = 28 | |||||
| Laparoscopic | 118 ± 120.3 | 249 ± 148.2 | 49.3 ± 82.1 | 232 ± 93 | 84.4 ± 78.4 | 0.001 | 0.001 | 0.660 | 0.152 |
| n = 19 | n = 24 | n = 22 | n = 20 | n = 19 | |||||
| Breast | 65 ± 59.3 | 309.6 ± 156.6 | 94.9 ± 129 | 258.6 ± 116.5 | 55.3 ± 77.6 | <0.001 | <0.001 | 0.061 | 0.058 |
| n = 22 | n = 59 | n = 56 | n = 48 | n = 58 | |||||
| Vaginal | 89.5 ± 70.5 | 260.2 ± 106 | 92.8 ± 117.5 | 168.7 ± 85.6 | 71.8 ± 80.8 | <0.001 | 0.006 | 0.007 | 0.532 |
| n = 14 | n = 18 | n = 18 | n = 19 | n = 19 | |||||
| Major | 111.1 ± 94.2 | 235 ± 83.1 | 41.1 ± 68.6 | 186.3 ± 98.3 | 89 ± 93.9 | <0.001 | <0.001 | 0.048 | 0.018 |
| n = 16 | n = 45 | n = 38 | n = 21 | n = 29 | |||||
| Intermediate | 181.2 ± 131.8 | 309.7 ± 167.7 | 99.9 ± 131.7 | 246.8 ± 111.8 | 58.6 ± 61.3 | <0.001 | <0.001 | 0.001 | 0.003 |
| n = 60 | n = 121 | n = 106 | n = 102 | n = 101 | |||||
| Minor | 116.5 ± 90.2 | 348.6 ± 225.7 | 103.2 ± 150.2 | 158.7 ± 101.2 | 60 .4 ± 57.4 | 0.002 | 0.116 | 0.05 | 0.439 |
| n = 9 | n = 12 | n = 11 | n = 7 | n = 9 | |||||
Amb PO1: ambulation on postoperative day 1; Amb IPO: ambulation during the immediate postoperative period.